These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8575036)

  • 61. Selective inhibition of the gastric H+,K(+)-ATPase by omeprazole and related compounds.
    Lorentzon P; Bayati A; Lee H; Andersson K
    Ann N Y Acad Sci; 1997 Nov; 834():592-9. PubMed ID: 9405870
    [No Abstract]   [Full Text] [Related]  

  • 62. Gastro protective and H(+), K(+)-ATPase/H. pylori inhibitory properties of pectic polysaccharides from potato.
    Badanavalu Chandrashekar K; Dharmesh SM
    Int J Biol Macromol; 2016 Mar; 84():385-93. PubMed ID: 26704999
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lansoprazole: a proton pump inhibitor.
    Garnett WR
    Ann Pharmacother; 1996 Dec; 30(12):1425-36. PubMed ID: 8968456
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Structure-activity study on antiulcer agents using Wiener's topological index and molecular connectivity index.
    Goel A; Madan AK
    J Chem Inf Comput Sci; 1995; 35(3):504-9. PubMed ID: 7797606
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pantoprazole.
    Poole P
    Am J Health Syst Pharm; 2001 Jun; 58(11):999-1008. PubMed ID: 11402494
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Studies on antiulcer drugs. IV. Synthesis and antiulcer activities of imidazo[1,2-a]pyridinylethylbenzothiazoles and -benzimidazoles.
    Katsura Y; Inoue Y; Nishino S; Tomoi M; Takasugi H
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1818-22. PubMed ID: 1356644
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.
    Nishioka K; Nagao T; Urushidani T
    Biochem Pharmacol; 1999 Oct; 58(8):1349-59. PubMed ID: 10487539
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pantoprazole treatment does not invoke anti-inflammatory properties in vivo.
    Becker TL; Maróstica M; Ribeiro ML; de Mendonça S; Gambero A; Pedrazzoli J
    Int Immunopharmacol; 2004 Aug; 4(8):1051-7. PubMed ID: 15222979
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A benzimidazole derivative (7110 MD) with gastric antisecretory and antiulcer activity.
    Dorme N; Raynaud G
    J Pharm Pharmacol; 1976 Oct; 28(10):788-9. PubMed ID: 10381
    [No Abstract]   [Full Text] [Related]  

  • 70. General pharmacology of IY-81149, a new proton pump inhibitor.
    Kim EJ; Lee RK; Lee SM; Kim DY
    Arzneimittelforschung; 2001 Jan; 51(1):51-9. PubMed ID: 11215326
    [TBL] [Abstract][Full Text] [Related]  

  • 71. E3710, a new proton pump inhibitor, with a long-lasting inhibitory effect on gastric acid secretion.
    Kodama K; Fujisaki H; Kubota A; Kato H; Hirota K; Kuramochi H; Murota M; Tabata Y; Ueda M; Harada H; Kawahara T; Shinoda M; Watanabe N; Iida D; Terauchi H; Yasui S; Miyazawa S; Nagakawa J
    J Pharmacol Exp Ther; 2010 Aug; 334(2):395-401. PubMed ID: 20484556
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reversible inhibitors of the gastric (H+/K+)-ATPase as both potential therapeutic agents and probes of pump function.
    Pope AJ; Sachs G
    Biochem Soc Trans; 1992 Aug; 20(3):566-72. PubMed ID: 1330781
    [No Abstract]   [Full Text] [Related]  

  • 73. Efficient synthesis and gastric (H+/K+)-ATPase-inhibitory activity of 2-aryl-4,5-dihydro-1H-thieno[3,2-e]benzimidazoles.
    Homma K; Watanabe T; Iijima T; Yato M; Matsuki K; Noto T; Ishida A
    Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):1945-54. PubMed ID: 9433764
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reversible inhibitors of the gastric H+/K(+)-transporting ATPase: a new class of anti-secretory agent.
    Pope AJ; Parsons ME
    Trends Pharmacol Sci; 1993 Sep; 14(9):323-5. PubMed ID: 8249153
    [No Abstract]   [Full Text] [Related]  

  • 75. Superpendentic index: a novel topological descriptor for predicting biological activity.
    Gupta S; Singh M; Madan AK
    J Chem Inf Comput Sci; 1999; 39(2):272-7. PubMed ID: 10192943
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Structure activity relationships of substituted benzimidazoles.
    Brändström A; Lindberg P; Junggren U
    Scand J Gastroenterol Suppl; 1985; 108():15-22. PubMed ID: 3858974
    [TBL] [Abstract][Full Text] [Related]  

  • 77. One-Pot Synthesis of Benzo[4,5]imidazo[1,2-a]pyrimidin-2-ones Using a Hybrid Catalyst Supported on Magnetic Nanoparticles in Green Solvents.
    Moussa A; Rahmati A
    ChemistryOpen; 2021 Aug; 10(8):764-774. PubMed ID: 34351084
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Studies on antiulcer agents. III. Plausible mechanism of antisecretory action of ethyl 2[(1H-benzimadazol-2-yl)sulfinylmethyl]-4-dimethylamino- 5-pyrimidinecarboxylate, an H+/K(+)-ATPase inhibitor, based on its reaction with thiols.
    Terashima K; Muraoka O; Ono M
    Chem Pharm Bull (Tokyo); 1995 Nov; 43(11):1985-91. PubMed ID: 8575036
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Studies on antiulcer agents. I. Synthesis and pharmacological properties of ethyl 2-[(1H-benzimidazol-2-yl)sulfinylmethyl]-4-dimethylamino-5- pyrimidinecarboxylate, a new H+/K(+)-ATPase inhibitor possessing mucosal protective activity.
    Terashima K; Shimamura H; Kawase A; Tanaka Y; Uenishi K; Kimura I; Ishizuka Y; Sato M
    Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):166-8. PubMed ID: 7895305
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Studies on proton pump inhibitors. II. Synthesis and antiulcer activity of 8-[(2-benzimidazolyl)sulfinylmethyl]-1,2,3,4-tetrahydroquinolines and related compounds.
    Uchida M; Chihiro M; Morita S; Kanbe T; Yamashita H; Yamasaki K; Yabuuchi Y; Nakagawa K
    Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2109-16. PubMed ID: 2557164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.